Detalhe da pesquisa
1.
Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk.
N Engl J Med
; 382(13): 1208-1218, 2020 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32050061
2.
Clinical Outcomes Before and After Complete Everolimus-Eluting Bioresorbable Scaffold Resorption: Five-Year Follow-Up From the ABSORB III Trial.
Circulation
; 140(23): 1895-1903, 2019 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31553222
3.
Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial.
Lancet
; 392(10157): 1530-1540, 2018 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30266412
4.
Polymer-Based Versus Polymer-Free Stents in High Bleeding Risk Patients: Final 2-Year Results From Onyx ONE.
JACC Cardiovasc Interv
; 15(11): 1153-1163, 2022 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35680195
5.
3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III Trial.
J Am Coll Cardiol
; 70(23): 2852-2862, 2017 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29100702